A D D E N D U M # 1 M U L T N O M A H C O U N T Y O R E G O N

Transcription

1 A D D E N D U M # 1 M U L T N O M A H C O U N T Y O R E G O N June 19, 2013 Address all questions to: Catherine Kwong, CPPB Multnomah County Purchasing 501 SE Hawthorne Boulevard, Suite 400 Portland, OR , Extension catherine.y.kwong@multco.us RFP NO: TITLE: Medical Laboratory Services NEW CLOSING July 1, 2013 / NOT LATER THAN 4:00 P.M. DATE: This Addendum is issued to the above referenced RFP to make the following changes, additions, deletions, and/or clarifications: 1. Change Closing date has been changed from June 24, 2013 to July 1, Delete and Replace Attachment 4, Cost Worksheet: Delete Attachment 4 in its entirety and replace with the as attached to this addendum. Notes: A. A new column Another Lab has been added. Please check if the answer is yes for each item. B. Item 82 has been replaced by Item 250 Transport Fee in the 82 Item Total. 3. Add, Cost Worksheet: Clarifications on some test items on the Cost Worksheet are attached to this addendum as Addendum 1 Attachment Delete and Replace Multnomah County Services Contract, Exhibit 2, Insurance Requirements: Delete Exhibit 2 and replace with the Revised Exhibit 2 as attached to this addendum as Addendum 1 Attachment Clarification Section 2.15, Insurance Requirements: Question: Please clarify insurance types required. Answer: Revised Exhibit 2 in the Multnomah County Services Contract Page 1 of 26

2 (Attachment 2) reflects the minimum insurance required of a Contractor to provide this service. Proof of self insurance programs will be considered. Additional insurance may be required. Final insurance requirements will be subject to negotiation between, and mutual agreement of, the parties prior to contract execution. 6. Clarification Section 2.7.9, Client Services Support: Question: Please clarify referral procedures. Answer: These are procedures for difficult blood draws and /or specialized blood draws that require special handling. 7. Clarification Section , Billing Services: Question: Clarify Payments received from Medicaid and Medicare constitute payment in full. Answer: Contractor will accept as payment in full the Medicare/aid reimbursement rates as published by CMS 8. Clarification Section 3.1, Proposal Questions Instructions: Question: Clarify how the point system works. Answer: Points will start from zero and increase. Total number of points available for each proposal is 100 and is scored per section as described in the table in Section 3.1. Proposers must answer all questions in 3.2, with the exception of question , Social Equity (see item 11 below), in which Proposers should answer questions in either Section A (if you have employees) or section B (if you do not have employees). 9. Clarification Question , Company Profile: Question: Please clarify key staff personnel. Answer: Submit credentials of your lab director, supervisors and lead technicians in your primary location. 10. Add Question 3.2.3, Patient Care and Service Delivery: Add the following question after item 7: 8. How many patient services centers do you have in Multnomah County? Add the following sentence to the end of evaluation criteria: Proposer has a good number of patient services centers in Multnomah County Page 2 of 26

3 11. Change Question , Page 20 and Page 23: Change the question number on top of Section A (Page 20) and Section B (Page 23) from to Change Question Employee Healthcare and Other Benefits: A. Employee Healthcare Change: (2% of total points) to (2 Points) Change: (0% of total points) to (0 Points) B. Other Benefits Sick Leave Change: (1% of total points) to (1 Points) Change: (0% of total points) to (0 Points) Vacation Benefits Change: (1% of total points) to (1 Points) Change: (0% of total points) to (0 Points) Retirement Benefits Change: (1% of total points) to (1 Points) Change: (0% of total points) to (0 Points) c: H. Liebrandt/K. Raisler C. Kwong K. BraemeBurr File 6/10/10 snt Page 3 of 26

4 1 COMP METAB PNL ,400 $ 2 HEMOGLOBIN A1C ,800 $ 3 HDLCHOLESTEROL ,200 $ 4 TSH (REFL) ,700 $ 5 CHOL TOTAL,(REFL) ,200 $ 6 TRIGLYCERIDES(REFL) ,200 $ 7 AUTOMATED PAP & RVW ,400 $ 8 CREATININE RAND (U) ,100 $ 9 CHOLESTEROL, TOTAL ,100 $ 10 TRIGLYCERIDES ,100 $ 11 DIRECT LDL ,100 $ HIV1/2 AB SCR W/RFLS to Western 12 Blot ,000 $ *MALB, RAND UR W/CR Random Microalbumin and Creatinine Ratio 13 MACR 82043, ,700 $ 14 HIV1 RNA,QN,RT PCR ,400 $ 15 CBC (DIFF/PLT) ,300 $ 16 HEP B SURF AG W/CONF ,300 $ 17 VIT D 25OH LC/MS/MS ,300 $ 18 BASIC METAB PNL ,000 $ 19 PM Profile 1 (urine 10 drug screen) (11) 1,000 $ 20 HEP C AB $ 21 TSH $ 22 T4, FREE $ 23 RUBELLA IMMUNE $ 24 AB SCR RFX ID/TITER $ 25 ABO GRP AND RH TYPE 86900, $ Page 1 of Page 4 of 26

5 26 RPR(DX)REFL FTA $ 27 IRON, TOTAL, & IBC 83540, $ 28 FERRITIN $ 29 GLUC, GEST SCRN Cut off Range $ 30 MICROALBUMIN RAND UR $ 31 VITAMIN B $ 32 FOLATE,SERUM $ 33 METHYLMALONIC ACID $ 34 LIPASE $ HEPATIC FUNC PNL CMS Approved 35 Panel $ 36 URIC ACID $ 37 HCG, TOTAL, QN $ 38 TESTOSTERONE, FR&TOT 84402, $ 39 HEP B SURFACE AB QN $ 40 HOMOCYSTEINE,NU/CON $ 41 PATH REVIEW, LIQ PAP $ 42 IVPATH, G&M, 1SP 88174, $ 43 OXYCODONE (U) $ 44 PSA, TOTAL $ CHLAMYDIA/GC RNA,Transcription 45 Mediated Amplification 87491, $ 46 MATERNAL SERUM SCR , 82397, 82677, 84702, $ 47 PRO TIME WITH INR $ 48 BNP $ 49 BILI, FRAC, PEDIATR , $ Page 2 of Page 5 of 26

6 50 VALPROIC ACID $ 51 LITHIUM $ 52 HEP A IGM AB $ 53 CULT, HSV+TYPING $ 54 HCV RNA BY PCR,QT $ 55 VZV IGG AB $ 56 HPV HR $ 57 ANA SCREEN $ 58 HEP B CORE AB, TOTAL $ 59 MAGNESIUM $ 60 CK, TOTAL $ 61 N. GONORRHOEAE RNA, TMA, $ 62 AMYLASE $ 63 HEP B SURF AB QL $ 64 PROLACTIN $ 65 HBC TOTAL W/REFL IGM $ 66 CRP $ 67 PHENYTOIN $ 68 H.PYLORI AG STOOL $ 69 ALT $ 70 FSH $ 71 HCV GENOTYPE LIPA $ 72 PTT, ACTIVATED $ 73 CCP AB IGG $ 74 CYTO, NONGYN FLUID(rectal) $ 75 CARBAMAZEPINE, TOTAL $ Page 3 of Page 6 of 26

7 76 RHEUMATOID FACTOR $ 77 PROTEIN ELECTRO , $ 78 HEPATITIS A AB,TOTAL $ 79 RETICULOCYTE COUNT $ 80 HEP A AB,W/REFL IGM $ 81 PTH,INTACT & CALCIUM 82310, $ 250 TRANSPORT FEE $ 82Item Total 82 HEP B CORE IGM AB BILIRUBIN, TOTAL *HEMOGLOBINOPATHY 83021, 85014, 85018, IMMUNOGLOBULIN A TTG IGA HIV1 GENOTYPE T4 (THYROXINE) GTT, GESTATIONAL, , SED RATE MANUAL WEST MUMPS VIRUS IGG, EIA GLIADIN IGA MEASLES AB IGG,EIA CALCIUM, IONIZED HSV TYPE RENAL FUNC PNL HGB INDICES 85014, 85018, HIV1 AB BY WBA GGT $ Page 4 of Page 7 of 26

8 100 TOXO IGG AB AFP,TUMOR (CHIRON) T3, FREE HSV 1/2 HERPESELECT 86695, PHOSPHATE (AS PHOS) T3 UPTAKE TROPONINI HEP B C AB, TOT (REFL) HBV DNA QUANT TESTOSTERONE, TOTAL TP RAND (U) W/ CREAT 82570, C DIFF TOXIN A&B DIGOXIN HPV HIGH RISK AR GLUCOSE, PLASMA AMMONIA (P) TTG IGG,IGA (2) RNP ANTIBODY HEP A AB, TOTAL LDH, TOTAL T3, TOTAL **HCV RNA QUALITATIVE PCR LH HLAB*5701 TYPING 83891, (30), 83900, ANA W/RFX ANTIDSDNA AB, EIA Page 5 of Page 8 of 26

9 126 LEAD, (B) POTASSIUM CHLAMYDIA/N. GON RNA, TMA 87491, GLUCOSE, SERUM HEP C AB (REFL) LYMPH SUBSET PNL , HSV TYPE CREATININE TP 24HR (U) W/CREAT 82570, Plasma Renin Assay LC/MS/MS ALDOSTERONE,LC/MS/MS CHROMATIN AUTO AB SM ANTIBODY SM/RNP ABS BILE ACIDS, TOTAL DDIMER QN CHILDHOOD ALLERGY PROFILE 82785, (15) CULTURE FUNGUS S/H/N HISTO SP STAIN GP I GTT, 2 SPEC LEVETIRACETAM HEP BE AG AST CORTISOL, A.M MATERNAL SERUM AFP TESTOSTERONE,T,LC/MS Page 6 of Page 9 of 26

10 152 IIIPATH, G&M, HCV W/REFL HCV RIBA JO1 ANTIBODY CBC(DIFF/PLT)W/SMEAR 85007, ANA TITER&PATTERN HEP BE AB **BENZODIAZEOINE; U IMMUNOFIXATION, SERUM PROTEIN ELECTRO , 84156, LAMOTRIGINE MITOCHONDRIAL W/REFL 86255, CULTURE, BLOOD INSULIN THYROID PEROXID AB LUPUS ANTICOAG W/RFL 85613, BUPRENORPHINE QN C. TRACHOMATIS RNA, TMA, **HCV RNA BDNA CK ISOENZYMES PHENOBARBITAL THYROGLOBULIN AB SCL METANPH.24 HR URINE TSH W/REFL FT MUMPS V AB(IGM) A1ANTITRYPSIN QN Page 7 of Page 10 of 26

11 178 CERULOPLASMIN PATH REVIEW OF SMEAR VZV AB IGM GLUCOSE, RAND (P) IGF I, ECL SS A RO AB(IGG)EIA SJOGRENS AB (SSB) ERYTHROPOIETIN CORTISOL, FREE 24HR CATECHOLAMINES, FRAC CREATININE (U) CULT, (U) ROUTINE 87086, G6PD (B) SICKLE CELL SCREEN HSV IGM AB SCREEN (2) CREATININE CLEARANCE SODIUM, RAND (U) 82570, METANEPHRINES,FRACT LH,3RD GENERATION OXCARBAZEPINE ANCA (2) HAPTOGLOBIN BILIRUBIN,DIRECT DHEASULFATE VALPROIC ACID, F & T (2) 203 HIV1 INTEGRASE Page 8 of Page 11 of 26

12 204 FSH,3RD GENERATION HIV2 AB,EIA 86689, PREALBUMIN KAPPA/LAMBDA W/RATIO (2) 208 SP, MANUAL SCREEN ESTROGEN, TOTAL (S) THEOPHYLLINE PROTEIN S, ACTIVITY SJOGREN'S ANTIBODIES (2) 213 **HEPATITIS C SUPPLEMENT MEASLES AB IGG,IGM (2) 215 CLONAZEPAM URINE CA ANTITHROMBIN III ACT FACTOR VIII ACTIVITY AMITRIPTYLINE OSMOLALITY PROTEIN ELECTRO, (U) 82570, 84156, RSV AG (IA) GLUCOSE, GEST. SCR PROTEIN C, ACT & AG 85302, H.PYLORI IGG AB ANTIBODY PANEL X CORTISOL, TOTAL OSMOLALITY (U) CEA Page 9 of Page 12 of 26

13 230 CA 24HR W/ CREAT 82340, EOSINOPHIL COUNT (U) SODIUM W/O CREAT RAND UR CRYP.AG EIA W/TITER 86406, Mircobiology organismis ID ALCOHOL, ETHYL (B) ESTRADIOL ANTITHROMBIN III AG EBV AB PANEL 86664, (2) 239 CARDIO CRP , 83898, 83909, 240 FACTOR V (LEIDEN) 83912, HBV DNA PCR, QUAL SHARED ASSAY COMP Delete Delete Delete 243 ALK PHOS ISOENZYMES 84075, ZINC (P) CHROMOSOME, BLOOD 88230, 88262, DAP (10) Delete Delete Delete 247 HSV IGM TITER ACTIN ANTIBODY (IGG) IGFBP Item Moved Item Moved Item Moved Item Moved Item Moved 251 ALDOLASE CALCIUM COPPER CPEPTIDE Page 10 of Page 13 of 26

14 255 IRON, TOTAL CARDIOLIPIN IGG AB CARDIOLP AB G/M/A (3) 258 PROTEIN,TOT,W/O CREAT PHOSPHOLIPID NEUT MALB, RAND UR W/O CR TPMT ACTIVITY TROFILE DNA HCG W/GEST TABLE PM Profile 1 + ALC(urine drug) (9) 265 DRVVT 1:1 MIX , (2), 266 HEREDITARY HEMO , 83909, *B.HENSELAE W/REFL (4) 268 OLANZAPINE SUSC1 micro suspectiblity 87181, 87184, RISTOCETIN COFACTOR , 83900, FRAGILE X PCR (2), HEPARIN ANTIXA LMWH PSA FREE & TOTAL 84153, ASO TOPIRAMATE CARDIOLP SC/RF (iga, igm, igg 276 Combined) (4) 276a CARDIOLP SC/RF (iga Only) (4) 276b CARDIOLP SC/RF (igm Only) (4) 276c CARDIOLP SC/RF (igg Only) (4) Page 11 of Page 14 of 26

15 277 STAT ASSAY VANCOMYCIN, TROUGH IMMUNOGLOBULIN E INTRINSIC FACTOR AB UA 24HR (U) 82570, RISPERIDONE / METAB, SP DRAW FEE, PSC SPEC CORTISOL, P.M CARDIOLIPIN IGM AB COMP C3C (2) 287 FRUCTOSAMINE CYCLOSP TR FPIA CALCIUM W/O CREAT 24 H UR ENDOMYSIAL IGA AB FENTANYL / METABOLITE, U STONE ANALYSIS HOMOCYSTEINE,CARDIO TOXO IGM EIA IMIPRAMINE VON WILLEBRAND AG HEP DELTA VIRUS AB SYNOVIAL FL ANALYSIS 83872, 89051, SUSCEPT AER MIC HIV1 CORECEPTOR TROPISM HEAVY METALS, 24HR (U) 82175, 83655, PROGESTERONE Page 12 of Page 15 of 26

16 303 IMCAP, PEANUT (F13) , 83894, 83900, 304 HBV GENOTYPE (4), TTG IGG IMMUNOGLOBULIN G IMMUNOGLOBULIN M BENZODIAZEPINES, QUANT,UR NORTRIPTYLINE CHLORIDE (U) 82436, POTASSIUM RAND (U) 82570, PROTHROMBIN GENE 83891, 83898, 83912, OPIATES, GC/MS (U) COOMBS, DIRECT PRIMIDONE 80184, HCG TOTAL QL , 85611, 85730, 317 MIXING STUDY (2) 318 CRYP.AG L.A. W/TITER OHPROGEST.LC/MSMS SB: TSI Thyroid Stimulating 320 Immuoglobulin LUPUS ANTICOAG HEX METHYLPHENIDATE ANTIBODY TITER X ACETAMINOPHEN COPPER (U) CLOZAPINE (CLOZARIL) Page 13 of Page 16 of 26

17 327 PROTEIN C, ACTIVITY CARDIOLIPIN IGA AB VON WILLEBRAND, MULT AMYLASE, RAND UR 82150, GLIADIN AB IGG/IGA (2) 332 TRANSPORT FEE ANTIPHOSPHATIDYLSER (3) 334 VITAMIN D,1, TRAMADOL SCN ;U METHYLPHENIDATE&MET;U HIV1 RNA QN BDNA , 82677, 84702, 338 MATERNAL SERUM B2GLYCO I(IGA) B2GLYCO I(IGM) B2GLYCO I(IGG) TRAMADOL&MET CFM;U BUN/CREAT RATIO 82565, DOXEPIN VITAMIN A IMCAP, EGG WHITE (F1) IMCAP, CODFISH (F3) IMCAP, TUNA (F40) IMCAP, SALMON (F41) CORTISOL, 2 SPEC 82533, H. PYLORI AB (IGG), WB ZONISAMIDE Page 14 of Page 17 of 26

18 353 LACTIC ACID, (P) REDUCING SUB, FECES SM & SM/RNP ABS (2) 356 TACROLIMUS, LC/MS/MS ACTH HGH THC METAB., GC/MS U , 88262, 88289, 360 CHROM HIGHRESOLUTION COCCI TOTAL AB,W/RFX IVPATH,G&M,1SP,TC 88305TC 363 T PALLIDUM AB BY PA METHADONE ETHOSUXIMIDE CMV IGG AB ABO GROUP RH TYPE VITAMIN B ALCOHOL, ETHANOL (U) IMCAP, MILK (F2) C DIFF TOXIN B QL CMV IGM AB GIARDIA AG DETECTION CHLORIDE W/O CREAT RAND , (2), 376 AAT MUTATION ANALY 83900, 83909, ANTIMULLERIAN Page 15 of Page 18 of 26

19 378 H. PYLORI IGG, QN DENGUE FEVER AB PNL (2) 380 STRONGYLOIDES IGG AB ANGIOTENSIN II CHSV RAPID METHOD , (2), (4), 83900, 383 TPMT GENOTYPE ANTIGEN TYPE X COAG FACTOR X ACT HIAA, 5, URINE HLAB27 ANTIGEN HETEROPHILE, MONO HANDLING CHARGE CULTURE, AEROBIC BAC CT,DIFF SYNOVIAL FL , 87106, 87107, 392 CULT,FUNGUS,SKIN 87143, 87149, VITAMIN B1,THIAMINE PARVO B19 IGG/IGM (2) 395 ALLERGY PNL REG , (23) 396 URORISK DIAG PROF 397 LEU & LYM 24 MARKERS 82340, 82507, 82570, 83735, 83945, 83986, 84105, 84133, 84300, 84392, , (23), Page 16 of Page 19 of 26

20 398 HSV 1/2 IGM AB, IFA 86695, DHEA, LC/MS/MS PRO PREDICTRX META ETG W/CONFIRM, U *ERROR* 402 C1 INHIBITOR, PROTEIN MERCURY (B) IMCAP, CRAB (F23) IMCAP, LOBSTER (F80) ALLERGY 13,PCS,Allergy testing for 406 insects allergy (5) 407 ELASTASE EL1, STOOL CENTROMERE AB, EIA CBC(DIFF/PLT)W/PATH 85025, SHBG PLT AB EXPANDED (3), (3) 412 GAD65 AB PTH, INTACT ISLET CELL AB INSULIN ABS, HIGHLY HBSAG CONFIRMATION AMIODARONE ISLET CELL RFX TITER (2) 419 ACHR BINDING AB ANTIDNASE B TITER GBM ANTIBODY CELL CT AND DIFF,CSF FIBRINOGEN QN Page 17 of Page 20 of 26

21 424 GLUCOSE, CSF PROTEIN, TOTAL, CSF VISCOSITY CULT,CMV RAPID/CONV 87252, CULT, VZV, RAPID VDRL, CSF PLASMINOGEN ACTIVITY CRYSTALS, SYN FLD LYME ABWB CONFIRM (2), , 83900, (13), 83909, 83912, 433 CF CARRIER SCREEN (32) 434 CKMB WITH RATIO 82550, CKMB (CK2) , 83900, 83909, 436 MTHFR, DNA MUTATION 83912, (2) 437 ACHR MODULATING AB , 83892, PROTHROMBIN GENE (2), 83908, ACHR BLOCKING CRYOGLOB EVAL CMV IGG AB W/REFL 86644, SHARED ASSAY COMP CYCLOSPORINE (B) T.VAGINALIS RNA,MALE AMPHETAMINES (U) Page 18 of Page 21 of 26

22 82140, 82340, 82507, 82570, 83735, 83945, 83986, 84105, 84133, 446 STONE RISK DIAG PROF 84300, 84392, CULT, NEISSERIA 87081, LD ISOENZYMES CULT, CHLAMYDIA 87110, METALS/METALLO PAN 1;SP 82175, 83655, CULTURE,AEROB/ANAER 87070, 87075, CULT,FUNGUS,OTHER 87102, INFLUENZA A&B AB, CF (2) 454 LACTOFERRIN DET THROMBINANTITH.TAT VONWILLEBRAND FACTOR HSV/VZV RAPID CULT (2) 458 HISTOPLASMA AG UR BILI, TOTAL PEDIATR SCHISTOSOMIASIS IGG ENTAMOEBA HIST CULTURE,RAPID FLU A&B (2) 463 RPR TITER PORPH FRAC RAND (U) OXYCODONE CONF (U) KAPPA/LAMBDA L CHAIN (2) 467 APC RESISTANCE ALKALINE PHOSPHATASE Page 19 of Page 22 of 26

23 469 COAG FACTOR XI ACT MYOGLOBIN, (U) RPR MONITOR W/REFL BETA2MICROGLOBULIN TRANSFERRIN VITAMIN C GABAPENTIN, PLASMA PORPHYRINS, FRAC (P) PORPHOBILINOGEN, RAND (U) PROTEIN, TOTAL LKM1 ANTIBODY(IGG) HLA CLASSI A,B,C DNA 83891, (90), (3), (3) 481 LEU & LYM 22 MARKERS 88184, (21), KAPPA/LAMBDA 24 HR U (2) 483 TRICHOMONAS VAG RNA, QL LGV DFF AB PNL MIF (8), (4) 485 MARIJUANA CONF GC/MS PTHRELATED PROTEIN COPPER;B Page 20 of Page 23 of 26

24 Worksheet Questions and Responses Addendum 1, Attachment 1 Question Response We would like to setup a test that runs the TSH and if abnormal it would automatically 4 TSH (REFL) Please clarify reflex reflexed to a free T4. AUTOMATED PAP & RVW Thin Prep Image Guided or Sure Path 7 methodology? With or without HPV? SurePath with the option to choose a reflex to HPV HIV1/2 AB SCR W/RFLS to Western 12 Blot Yes reflex to a WesternBlot if screen positive *MALB, RAND UR W/CR 13 Microalbumin? Random , Yes a random Microalbumin and Creatinine Ratio MACR HEP B SURF AG W/CONF With reflex to confirmation by nutralization with Hep 16 BSAB? Yes that is correct PM Profile 1 (urine 10 drug screen) Which components are included in this 19 panel? (11) The following drugs should be included: Amphetamines, Barbiturates, Benzodiazepines, Marijuana metabolites, Methadone, Opiates, Oxycodone, Phencyclidine, Propoxyphene GLUC, GEST SCRN 140 what is the ? Cutoff range HEPATIC FUNC PNL The CMS 35 approved panel? Yes that is correct 42 IVPATH, G&M, 1SP Please clarify 88174, Cost of additonal tests done on a positive tissue sample OXYCODONE (U) We are not familiar 43 with S and C. We test for oxycodone Disreagard the S & C CHLAMYDIA/GC RNA,TMA please 45 define TMA 87491, TranscriptionMediated Amplification (TMA) AFP, unconjugated Estriol, hcg, Dimeric Inhibin A, ITA (hyperglycoslated hcg), and Marternal Risk Intrepretation MATERNAL SERUM SCR 5 would you 82105, 82397, 82677, 46 please list the components? 84702, PRO TIME WITH INR Assess prenatal risk for NTD's, Down syndrome, and trisomy LYMPH SUBSET PNL 3 please clarify 86359, Test for Abs Lymphs % CD3, Abs CD3, % CD4, Abs CD4, %CD8, Abs CD8, CD4/CD8 ratio 135 PRA LC/MS/MS Please clarify Plasma Renin Assay MITOCHONDRIAL W/REFL please 162 clarify 86255, AB with reflex to a titre 234 ORG ID 1 Please clarify Mircobiology organismis ID 242 SHARED ASSAY COMP please clarify Item to be deleted 246 DAP 10 please clarify components (10) Item to be deleted Page 1 of Page 24 of 26

25 Worksheet Questions and Responses Addendum 1, Attachment 1 Question Response (NEW LOCATION item has been moved and is now located after Item 81) STAT pickups that fall outside the normal pickup schedule and could be done at either the clinic sites or 250 TRANSPORT FEE 10 Please clarify from our main laboratory. PM Profile 1 + ALC(urine drug) Please 264 include components (9) See item 19 + Alcohol 269 SUSC1 please clarify 87181, 87184, micro suspectiblity 276 CARDIOLIPID (iga, IgM, IgG) (4) Cost for all three plus breakout of each separtely (added 276ac to revised worksheet) 277 STAT ASSAY 1 Which assay? Do you charge for doing a test STAT? 299 SUSCEPT AER MIC Please clarify Aerobic organism MIC cost. 320 TSI Please clarify SB: TSI Thyroid Stimulating Immuoglobulin 362 IVPATH,G&M,1SP,TC please clarify 88305TC Cost of a tissue evaluation that is positive. Additional slide preparation 406 ALLERGY 13,PCS,INSCT Please clarify (5) Allergy testing for insects allergy 450 METALS/METALLO PAN 1;SP please clarify 82175, 83655, Heavy metals assay: arsenic, lead, Mercury, and maybe cadmium Page 2 of Page 25 of 26

26 EXHIBIT 2 MULTNOMAH COUNTY SERVICES CONTRACT Contract No. [Insert Contract Number] INSURANCE REQUIREMENTS Contractor shall at all times maintain in force at Contractor s expense, each insurance noted below: ** Workers Compensation insurance in compliance with ORS , which requires subject employers to provide workers compensation coverage in accordance with ORS Chapter 656 or CCB (Construction Contractors Board) for all subject workers. Contractor and all subcontractors of Contractor with one or more employees must have this insurance unless exempt under ORS (See Exhibit 4). Employer s Liability Insurance with coverage limits of not less than $500,000 must be included. THIS COVERAGE IS REQUIRED. Attach Certificate of Insurance. If Contractor does not have coverage and claims to be exempt, attach Exhibit 4 in lieu of Certificate. Professional Liability insurance with a combined single limit of not less than $1,000,000 each claim, incident, or occurrence, with an annual aggregate limit of $2,000,000. This is to cover damages caused by error, omission, or negligent acts related to professional services provided under this Contract. The policy must provide extended reporting period coverage for claims made within two years after this Contract is completed. Required by County Not required by County (Needs Risk Manager s Approval) Commercial General Liability insurance, on an occurrence basis, with a combined single limit of not less than $1,000,000 each occurrence for Bodily Injury and Property Damage, with an annual aggregate limit of $2,000,000. This insurance must include contractual liability coverage. Required by County Not required by County (Needs Risk Manager s Approval) Commercial Automobile Liability insurance with a combined single limit, or the equivalent of not less than $1,000,000 each occurrence for Bodily Injury and Property Damage, including coverage for owned, hired or nonowned vehicles. Required by County Not required by County (Required if vendor is transporting and/or driving as part of performing the duties specified in the contract) Additional Requirements. Coverage must be provided by an insurance company authorized to do business in Oregon or rated A or better by Best s Insurance Rating. Contractor shall pay all deductibles and retentions. A crossliability clause or separation of insureds condition must be included in all commercial general liability policies required by this Contract. Contractor s coverage will be primary in the event of loss. The County must be listed as an Additional Insured by Endorsement on to any General Liability Policy on a primary and noncontributory basis. Such coverage will specifically include products and completed operations coverage. Certificate of Insurance Required. Contractor shall furnish a current Certificate of Insurance to the County. The Contractor shall immediately notify the County of any change in insurance coverage. The Certificate shall also state the deductible or retention level. For general liability the Certificate shall also state the following: Additional Insured Form (include form number) attached. This form is subject to policy terms, conditions and exclusions. A copy of the additional insured endorsement shall be attached to the certificate of insurance required by this contract. If requested, complete copies of insurance policies shall be provided to the County. Where in the County to send your Certificate of Insurance. Risk Management has an address that all insurance certificates should be sent to: insurance@multco.us. Additional originals, hard copies, or faxes are not necessary. Completed by: Contract Originator **Note to Contract Originator: For certain types of contracts additional insurance may be required. Refer to the Contract Insurance and Indemnification Manual or contact Risk Management/ Property & Liability Programs Page 26 of 26